Organogenesis Inc.
Company Information

150 Dan Rd Ste 3
Canton, MA, 02021 United States
(781) 575-0198

Top 3 Competitors

Unlock access to all reports with a Hoover's Professional Subscription
Call (866) 473-3932 today to get
started with a FREE TRIAL!

  • Up-to-the moment intelligence helps you set strategy, prepare for sales calls, and close business.
  • Easy-to-read reports on over 85 million companies and 900 industries build your understanding of the companies you work with.
  • High-quality, reasonably-priced reports save you hours of costly research.

Unlock a Hoover's Basic Subscription.
To talk to a Business Information Consultant please call (866) 473-3932


Organogenesis Inc. Company Profile

Organogenesis has the skinny on replacement tissue. Its flagship product, Apligraf, is a human skin substitute approved to treat diabetic foot ulcers and venous leg ulcers caused by poor circulation. It has delivered more than 500,000 units of Apligraf for patient treatment. Rejection-resistant Apligraf is bio-engineered using living skin cells and has been used to treat chronic open wounds. Founded in 1985, the company is developing a next-generation of the material using all human components via its VCT technology. It also offers a line of biomaterials used in a range of surgical procedures to seal or reconstruct soft tissue and develops regenerative technologies in the area of cosmetic skin rejuvenation.